XPH vs. IHI
XPH (SPDR S&P Pharmaceuticals ETF) and IHI (iShares U.S. Medical Devices ETF) are both Health & Biotech Equities funds - XPH tracks the S&P Pharmaceuticals Select Industry Index while IHI tracks the Dow Jones U.S. Select Medical Equipment Index. Both are passively managed. Over the past 10 years, XPH returned 3.57%/yr vs 8.86%/yr for IHI. A 0.66 correlation means they provide meaningful diversification when combined. XPH charges 0.35%/yr vs 0.43%/yr for IHI.
Performance
XPH vs. IHI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XPH achieves a 3.48% return, which is significantly higher than IHI's -19.70% return. Over the past 10 years, XPH has underperformed IHI with an annualized return of 3.57%, while IHI has yielded a comparatively higher 8.86% annualized return.
XPH
- 1D
- 2.80%
- 1M
- -3.15%
- YTD
- 3.48%
- 6M
- 6.97%
- 1Y
- 41.81%
- 3Y*
- 14.00%
- 5Y*
- 4.07%
- 10Y*
- 3.57%
IHI
- 1D
- 2.76%
- 1M
- 0.16%
- YTD
- -19.70%
- 6M
- -21.09%
- 1Y
- -19.03%
- 3Y*
- -2.23%
- 5Y*
- -1.96%
- 10Y*
- 8.86%
XPH vs. IHI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
XPH SPDR S&P Pharmaceuticals ETF | 3.48% | 31.60% | 4.94% | 2.97% | -9.83% | -10.54% | 14.68% | 25.61% | -15.32% | 12.05% |
IHI iShares U.S. Medical Devices ETF | -19.70% | 6.88% | 8.62% | 3.24% | -19.80% | 21.03% | 24.17% | 32.75% | 15.45% | 30.81% |
Correlation
The correlation between XPH and IHI is 0.45, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.45 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.50 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.59 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.60 |
Correlation (All Time) Calculated using the full available price history since Jun 23, 2006 | 0.66 |
Over the past year, the correlation between XPH and IHI has dropped to 0.45 - well below their long-term average of 0.66, suggesting their price drivers have been diverging.
XPH vs. IHI - Sectors Allocation Comparison
Sectors
XPH
IHI
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
XPH
IHI
Basic Materials
XPH
-
IHI
-
Communication Services
XPH
-
IHI
-
Consumer Cyclical
XPH
-
IHI
-
Consumer Defensive
XPH
-
IHI
-
Energy
XPH
-
IHI
-
Financial Services
XPH
-
IHI
-
Industrials
XPH
-
IHI
Real Estate
XPH
-
IHI
-
Technology
XPH
-
IHI
-
Utilities
XPH
-
IHI
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XPH vs. IHI — Risk / Return Rank
XPH
IHI
XPH vs. IHI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Pharmaceuticals ETF (XPH) and iShares U.S. Medical Devices ETF (IHI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XPH | IHI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.06 | ||
| Sortino ratioReturn per unit of downside risk | +4.28 | ||
| Omega ratioGain probability vs. loss probability | 1.32 | 0.83 | +0.49 |
| Calmar ratioReturn relative to maximum drawdown | 3.51 | -0.73 | +4.24 |
| Martin ratioReturn relative to average drawdown | 12.47 | -1.85 | +14.33 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| XPH | IHI | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.94 | -1.13 | +3.06 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.20 | -0.10 | +0.30 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.16 | 0.45 | -0.29 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.39 | 0.47 | -0.08 |
Drawdowns
XPH vs. IHI - Drawdown Comparison
The maximum XPH drawdown since its inception was -48.03%, roughly equal to the maximum IHI drawdown of -49.65%. Use the drawdown chart below to compare losses from any high point for XPH and IHI.
Loading charts...
Drawdown Indicators
| XPH | IHI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -48.03% | -49.65% | +1.62% |
Max Drawdown (1Y)Largest decline over 1 year | -11.97% | -26.11% | +14.14% |
Max Drawdown (3Y)Largest decline over 3 years | -23.57% | -26.64% | +3.07% |
Max Drawdown (5Y)Largest decline over 5 years | -31.63% | -33.12% | +1.49% |
Max Drawdown (10Y)Largest decline over 10 years | -35.97% | -33.25% | -2.72% |
Current DrawdownCurrent decline from peak | -4.63% | -24.17% | +19.54% |
Average DrawdownAverage peak-to-trough decline | -17.25% | -8.32% | -8.93% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.36% | 10.29% | -6.93% |
Volatility
XPH vs. IHI - Volatility Comparison
SPDR S&P Pharmaceuticals ETF (XPH) has a higher volatility of 7.54% compared to iShares U.S. Medical Devices ETF (IHI) at 7.01%. This indicates that XPH's price experiences larger fluctuations and is considered to be riskier than IHI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XPH | IHI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.54% | 7.01% | +0.53% |
Volatility (6M)Calculated over the trailing 6-month period | 16.85% | 13.05% | +3.80% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.68% | 16.96% | +4.72% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.88% | 18.99% | +1.89% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.11% | 19.79% | +2.32% |
XPH vs. IHI - Expense Ratio Comparison
XPH has a 0.35% expense ratio, which is lower than IHI's 0.43% expense ratio.
Dividends
XPH vs. IHI - Dividend Comparison
XPH's dividend yield for the trailing twelve months is around 0.64%, more than IHI's 0.45% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IHI iShares U.S. Medical Devices ETF | 0.45% | 0.34% | 0.46% | 0.53% | 0.45% | 0.25% | 0.25% | 0.33% | 0.26% | 0.37% | 0.55% | 1.28% |
XPH SPDR S&P Pharmaceuticals ETF | 0.64% | 0.83% | 1.58% | 1.28% | 1.64% | 0.95% | 0.47% | 0.64% | 0.65% | 0.67% | 0.63% | 7.15% |
Frequently Asked Questions
XPH and IHI have a correlation of 0.45, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XPH has higher volatility (7.54%) compared to IHI (7.01%). In terms of maximum drawdown, XPH dropped -48.03% vs IHI's -49.65%.
On 10-year performance, IHI leads with 8.86% vs 3.57% for XPH. On fees, XPH is cheaper at 0.35% per year. On volatility, IHI has been the lower-risk option at 7.01%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, IHI has performed better with a 8.86% return vs 3.57%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XPH is cheaper with a 0.35% expense ratio, compared with 0.43% for IHI.
XPH has the higher dividend yield at 0.64%, compared with 0.45% for IHI.
XPH tracks S&P Pharmaceuticals Select Industry Index, while IHI tracks Dow Jones U.S. Select Medical Equipment Index. They also come from different issuers: State Street and iShares. Their fees differ too: 0.35% for XPH and 0.43% for IHI.
XPH currently has the higher Sharpe Ratio (1.94 vs -1.13), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XPH and IHI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer